Skip to main content
SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. logo

SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. — Investor Relations & Filings

Ticker · 688238 ISIN · CNE1000059N9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 482 across all filing types
Latest filing 2026-05-13 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688238

About SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD.

https://www.obio-tech.com/

SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the gene and cell therapy (GCT) sector. The company provides end-to-end solutions encompassing vector construction, process development, analytical method development, and large-scale GMP manufacturing. Its service portfolio includes the production of viral vectors such as adeno-associated virus (AAV), lentivirus, adenovirus, and oncolytic viruses, as well as plasmid DNA and cell therapy products. Obio Technology supports clients from early-stage research through clinical trials to commercialization. The company operates advanced facilities designed to meet international regulatory standards, facilitating the development of innovative genetic medicines and advanced therapies for global biopharmaceutical partners.

Recent filings

Filing Released Lang Actions
上海市金茂律师事务所关于上海和元生物技术（集团）股份有限公司2025年年度股东会之法律意见书
Regulatory Filings Classification · 75% confidence The document is a legal opinion letter issued by a law firm regarding the convening procedures, participant qualifications, voting procedures, and legality of resolutions at the company’s 2025 annual shareholders’ meeting. It is not the annual report or a financial statement, nor a simple notice of publication. It is also not a management presentation or proxy solicitation document in the usual sense; rather it is a standalone legal compliance opinion filed with the stock exchange. No specialized category (e.g., audit report, earnings release, proxy statement) matches a legal opinion letter, so it falls into the general “Regulatory Filings” (RNS) catch‐all category.
2026-05-13 Chinese
2025年年度股东会会议资料
AGM Information Classification · 100% confidence The document is titled '2025年年度股东会会议资料' which translates to '2025 Annual General Meeting (AGM) Meeting Materials'. It contains detailed agenda, proposals, voting procedures, and reports related to the 2025 Annual General Meeting of Shanghai Obio Technology (Group) Corp., Ltd. The content includes meeting notices, agenda items, board reports, profit distribution proposals, remuneration proposals, and other materials typically shared with shareholders for an AGM. The document is lengthy (15,000 characters) and contains the full meeting materials, not just an announcement or a brief summary. Therefore, it fits the category of AGM Information (AGM-R).
2026-05-07 Chinese
2025年度募集资金年度存放、管理与实际使用情况鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as a "募集资金年度存放、管理与实际使用情况鉴证报告" which translates to "Annual Verification Report on the Deposit, Management, and Actual Use of Raised Funds" for the year 2025. It includes detailed financial data about the raised funds, their management, usage, and compliance with regulatory rules such as the "上市公司募集资金监管规则" (Regulations on the Supervision of Raised Funds for Listed Companies) and Shanghai Stock Exchange guidelines. The report is prepared by management and independently verified by a certified public accounting firm, including their licenses and certifications attached. The document is comprehensive, contains substantive financial data and analysis about the use of capital raised by the company, and is not merely an announcement or certification. This type of report is a specialized audit or assurance report focusing on the use of capital raised by the company, which fits best under the category of Audit Report / Information (AR). It is not a full Annual Report (10-K), nor a simple announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2025
2026-04-20 Chinese
关于使用自有闲置资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from the company's board regarding the decision to use idle funds for cash management. It details the investment purpose, amount, risk control measures, and the board meeting resolution approving this use of funds. There are no financial statements, quarterly or annual results, or detailed financial data presented. The document is relatively short (1477 characters) and serves as a formal disclosure of a financing-related decision rather than a full financial report. This fits the definition of a Capital/Financing Update (CAP) as it updates on the company's financing activities and capital usage.
2026-04-20 Chinese
2025年度内部控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled '2025 年度内部控制审计报告' which translates to '2025 Internal Control Audit Report'. It is issued by a certified accounting firm and includes detailed audit opinions on the effectiveness of internal controls over financial reporting as of December 31, 2025. The document contains the auditor's responsibilities, the company's responsibilities, and the audit opinion on internal control effectiveness. It also includes attachments such as business licenses and CPA certificates, which support the audit report. The document length is 2765 characters, which is relatively short but contains substantive audit content rather than just an announcement or certification. This matches the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles. It is not an Annual Report (10-K) or Interim Report (IR) because it focuses solely on internal control audit results, not full financial statements or comprehensive company performance. It is not a Regulatory Filing (RNS) because it contains substantive audit content, not just certifications or attestations. Therefore, the correct classification is AR with high confidence. FY 2025
2026-04-20 Chinese
《2025年度独立董事述职报告》（侯绪超）
Board/Management Information Classification · 95% confidence The document is titled '2025年度独立董事述职报告（侯绪超）' which translates to '2025 Annual Independent Director's Work Report (Hou Xuchao)'. It is a detailed report by an independent director about his duties, attendance at board and committee meetings, communication with auditors, and evaluation of company governance and financial reporting during the 2025 fiscal year. The content focuses on the independent director's responsibilities, observations, and opinions rather than financial statements or audit results. It includes references to board and management changes but is primarily a director's report on his work and oversight activities. This type of document fits best under 'Board/Management Information (MANG)' as it relates to management and board activities and personnel changes, rather than being a full annual report, audit report, or regulatory filing. The document length (6846 characters) and detailed content support this classification with high confidence.
2026-04-20 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.